“Plaques and Tangles” play asks: Would you take genetic test for your fate?

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. 

You have a 50-percent chance of carrying a gene that will radically change and then destroy your life. Do you want to know if you have it?

This decision is at the heart of Plaques and Tangles, Nicola Wilson’s first play, on now at the Royal Court in London. The protagonist is Megan, brilliantly played by Monica Dolan, who we see at various stages of her life.

Her mother has died of early-onset Alzheimer’s, a rare type of the disease, and Megan faces a dilemma that is becoming more and more common. Does she take a test that might lay bare her destiny?

The reality is that genetic testing for conditions like Alzheimer’s is becoming common. If you are at risk, like Megan, because a parent has a disease with a known genetic component, then in the UK, the National Health Service will offer you a test and often counseling, too.

But there are now a large number of companies offering tests, like 23&Me, which recently relaunched its consumer service. 23&Me offers tests for 36 diseases, but it doesn’t offer counseling. After the result, you’re on your own.

So as a subject for a play, it is timely. Other writers feel it too. Lisa Genova, author of Still Alice, which was made into a film last year starring Julianne Moore as a woman with Alzheimer’s, has a new novel out. Inside the O’Briens is about a man with Huntington’s disease and the struggle his children face about deciding whether or not to get tested.

Read full, original post: Would you take a genetic test that could lay bare your destiny?

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
Personalized-Cancer-mRNA-Vaccine-Vial
Personalized mRNA vaccines are poised to revolutionize cancer treatments. Here are the barriers.
AI Doctor with a Digital Neural Head
Utah becomes first state to empower AI to bypass doctors and prescribe certain drugs
AI-Force-Uniform-Insignia-Close-Up
Trump wants an AI Force like Space Force, but that could make AI’s risks harder to manage
Radioactive-Americana-Collage-2
The kooky logic behind the raft of spurious cancer claims from Harvard’s T.H. Chan School of Public Health
Deepfake Democracy Media Mosaic
31 states have passed a patchwork of laws to limit election deepfake commercials. They’re not working very well.
Screenshot-2026-09-22-at-10.54.12-AM
‘They misunderstand science’: Research attempting to tie autism to changes in the gut microbiome comes under fire
Screenshot-2026-10-05-at-11.57.44-AM
Scaremongering or legitimate safety concerns? The political dogfight over America’s food safety system
Screenshot-2026-10-11-at-8.10.44-PM
Tearful onions? CRISPR has a solution for that
Screenshot-2026-10-08-at-1.23.28-PM
Countries around the world are rushing to pass teenage social media bans. Could they backfire?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.